Leukemia
Conditions
Keywords
bone marrow transplant, infection, computed tomography, radiation dose
Brief summary
Patients with bone marrow cancer are more susceptible to chest infections than healthy adults; marrow ablation treatment further compromises their immune status and increases the risk of fungal opportunistic infection, which is associated with a high fatality rate. Therefore, it is critical to achieve early and accurate diagnosis of fungal infection when these patients become febrile. At the Mount Sinai Hospital (MSH) and the University Health Network (UHN), the standard of care (SOC) to exclude a chest infection in immunocompromised (IC) patients is chest computed tomography (CT) using low dose CT (LDCTT).
Detailed description
As patients may have several febrile episodes during their hospital stay, the cumulative dose from LDCTT scans can be significant and increase the lifetime risk of inducing a second cancer. The aim of this project is to determine whether a 75% reduction in radiation dose for LDCTT in other words, an ultralow dose chest CT (uLDCTT) at a dose comparable to chest X-ray, maintains the diagnostic image quality for detection of fungal chest infection in IC patients. If successful, uLDCTT will be adopted as SOC imaging at Princess Margaret Cancer Center (PM) for these patients.
Interventions
Ultralow dose chest CT (uLDCTT) at a radiation dose comparable to 2 chest X-rays
Sponsors
Study design
Eligibility
Inclusion criteria
1. All immunocompromised patients clinically referred for LDCTT to the Medical Imaging department at PM 2. 18 years and older
Exclusion criteria
1. Patients that cannot follow study procedures
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Image acquisition | Study Day 1 | Perform paired clinical low dose (LDCTT) and research ultralow dose (uLDCTT) chest CT in immunocompromised (IC) patients who present with febrile neutropenia (FN) and are clinically referred for LDCTT to exclude opportunistic fungal infection. |
Countries
Canada